Anebulo Pharmaceuticals, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Jun 2020 | — | $-171.1K | $3.0M |
| Sep 2020 | — | $-411.1K | — |
| Dec 2020 | — | $-719.0K | — |
| Mar 2021 | — | $-9.4M | $3.3M |
| Jun 2021 | — | $21.4M | — |
| Sep 2021 | — | $19.9M | — |
| Dec 2021 | — | $18.9M | — |
| Mar 2022 | — | $17.2M | — |
| Jun 2022 | — | $15.1M | — |
| Sep 2022 | — | $19.1M | — |
| Dec 2022 | — | $15.5M | — |
| Mar 2023 | — | $12.9M | — |
| Jun 2023 | — | $10.6M | $11.2M |
| Sep 2023 | — | $8.3M | $8.5M |
| Dec 2023 | — | $6.5M | $6.6M |
| Mar 2024 | — | $5.0M | $5.1M |
| Jun 2024 | — | $3.8M | $3.1M |
| Sep 2024 | — | $1.9M | $1.4M |
| Dec 2024 | — | $15.0M | $15.0M |
| Mar 2025 | — | $13.5M | $13.3M |
| Jun 2025 | — | $11.7M | $11.6M |
| Sep 2025 | — | $9.7M | $10.4M |
| Dec 2025 | — | $7.9M | $9.0M |